Director at Cyabra (NASDAQ: CYAB) receives 14,436 fully vested stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination. The award covers options to buy 14,436 shares of common stock at an exercise price of $1.00 per share, expiring on January 8, 2035.
According to the footnotes, this option replaces a prior Cyabra Strategy Ltd. option for 4,000 ordinary shares under the merger agreement with Trailblazer Merger Corporation I. After this grant, Madon holds options covering 14,436 shares, reflecting compensation and equity alignment following the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Madon Michael P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option(Right to Buy) | 14,436 | $0.00 | -- |
Holdings After Transaction:
Stock Option(Right to Buy) — 14,436 shares (Direct)
Footnotes (1)
- The options were fully vested upon grant. Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer. Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 4,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan.
Key Figures
Option grant size: 14,436 options
Exercise price: $1.00 per share
Post-transaction option holdings: 14,436 options
+2 more
5 metrics
Option grant size
14,436 options
Stock options to buy common stock reported on March 27, 2026
Exercise price
$1.00 per share
Exercise price for the 14,436-share option grant
Post-transaction option holdings
14,436 options
Total options held following the reported transaction
Expiration date
January 8, 2035
Option expiration for the reported grant
Prior Cyabra option size
4,000 ordinary shares
Original Cyabra option converted under the merger agreement
Key Terms
Business Combination, Merger Agreement, Effective Time, Omnibus Equity Incentive Plan, +1 more
5 terms
Business Combination financial
"together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination""
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
Merger Agreement financial
"in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended"
A merger agreement is a binding contract that lays out the exact terms for two companies to combine, including the price, what each side will deliver, and the conditions that must be met before the deal is completed. Investors care because it sets the timetable, payouts and risks — like a blueprint or prenup that shows whether the deal is likely to close, how ownership will change, and what could cancel or alter the payout they expect.
Effective Time financial
"that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time")"
Omnibus Equity Incentive Plan financial
"pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan"
A single, company-wide plan that lets a business grant different kinds of stock-based pay — such as stock options, shares that vest over time, or other equity awards — to employees, directors and consultants. It matters to investors because it determines how much of the company can be paid out in shares, how quickly those shares enter the market, and how well employees are motivated to grow the business; think of it as a toolbox or menu for paying with ownership stakes that can dilute existing holders and affect company performance.
stock option financial
"each option to purchase ordinary shares of Cyabra held by the Reporting Person"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did CYAB (Cyabra, Inc.) director Michael P. Madon receive in this Form 4 filing?
Michael P. Madon received a fully vested stock option grant for 14,436 shares of Cyabra, Inc. common stock. These options represent equity-based compensation linked to the company’s recent business combination, giving him the right to buy shares at a fixed price.
What is the exercise price and expiration date of Michael Madon’s CYAB options?
The options allow Michael Madon to buy Cyabra, Inc. common stock at an exercise price of $1.00 per share. They are scheduled to expire on January 8, 2035, providing a long-term window to exercise this equity award if he chooses.
Were Michael Madon’s CYAB options vested at the time of grant?
Yes, the options were fully vested upon grant according to the footnotes. This means Madon does not need to satisfy additional service or performance conditions before exercising, beyond paying the $1.00 per-share exercise price when he exercises.